Related Experiment Videos
Dermatologic drug use during pregnancy and lactation
1University of Colorado Health Sciences Center, Denver, USA.
Dermatologic Clinics
|January 1, 1997
Summary
This review guides physicians on selecting dermatologic drugs for women of childbearing age, focusing on interactions with oral contraceptives and safety during pregnancy and lactation. It details corticosteroids and tretinoin, offering guidelines for safe prescription practices.
Area of Science:
- Dermatology
- Pharmacology
- Reproductive Health
Background:
- Physicians frequently prescribe dermatologic medications to women of childbearing potential.
- Assessing drug safety during pregnancy and lactation is crucial for this demographic.
- Understanding drug interactions, particularly with hormonal contraceptives, is essential.
Purpose of the Study:
- To review dermatologic drugs and their impact on contraceptive efficacy.
- To identify medications to avoid in women of childbearing age.
- To provide guidance on selecting safe dermatologic treatments during pregnancy and lactation.
Main Methods:
- Comprehensive literature review of dermatologic drugs.
- Analysis of reported interactions with contraceptive efficacy.
- Evaluation of contraindications for use during pregnancy and lactation.
- Detailed discussion of corticosteroids and tretinoin.
Main Results:
- Certain dermatologic drugs can reduce contraceptive efficacy.
- Specific medications are contraindicated during pregnancy and lactation.
- Corticosteroids and tretinoin have distinct safety profiles and usage guidelines.
- Sources and guidelines for drug selection are presented.
Conclusions:
- Informed prescribing of dermatologic medications is vital for women of childbearing age.
- Careful consideration of drug interactions and pregnancy/lactation safety is necessary.
- This review provides a framework for evidence-based dermatologic prescribing in this population.